DOSSIER · 13F-HR · Q2 2026

Birchview Capital, LP

$214M in tracked AUM across 73 positions as of Q2 2026.

BC
CIK 0001618205 · last filed Jun 30, 2026
Total AUM
$214M
as of Q2 2026
Holdings
73
positions
Whale Score
57
57
tracked
Activity
no data
changes this Q
AI Analysis · Q2 2026

Birchview Capital, LP filed its latest 13F-HR for Q2 2026. See the latest holdings and position changes below.

Quarter at a glance — Q2 2026

Position-change comparison pending.

No quarter-over-quarter changes available.

Top 10 holdings

By portfolio weight as of Q2 2026.

#HoldingValueSharesWeight
01
KLAC
KLA CORPORATION
$54M178K25.2%
02
BMY
BRISTOL-MYERS SQUIBB CO
$17M297K8.0%
03
LRCX
LAM RESEARCH CORPORATION
$15M35K7.1%
04
NTLA
INTELLIA THERAPEUTICS INC (NTLA) C @ 13.0 10/16/2026
$7M386K3.2%
05
SLDB
SOLID BIOSCIENCES INC
$7M666K3.1%
06
09075X108
BIODESIX INC
$6M287K3.0%
07
STOK
STOKE THERAPEUTICS INC
$6M178K2.7%
08
OVV
OVINTIV INC
$6M108K2.6%
09
NKTR
NEKTAR THERAPEUTICS
$6M81K2.6%
10
CORT
CORCEPT THERAPEUTICS INC
$5M57K2.3%

Filing history

2026Q2Jun 30
$214M 21.7%
73 positionsView →
2026Q1Mar 31
$176M 2.8%
73 positionsView →
2025Q4Dec 31
$171M 149.3%
68 positionsView →
2025Q3Sep 30
$69M 32.0%
50 positionsView →
2025Q2Jun 30
$101M 106.6%
71 positionsLocked
2025Q1Mar 31
$49M 60.3%
48 positionsLocked
2024Q4Dec 31
$123M 6.5%
68 positionsLocked
2024Q3Sep 30
$115M 6.7%
62 positionsLocked
2024Q2Jun 30
$108M 11.9%
61 positionsLocked
2024Q1Mar 31
$122M 4.0%
60 positionsLocked
2023Q4Dec 31
$128M 8.6%
59 positionsLocked
2023Q3Sep 30
$117M 11.9%
52 positionsLocked
Showing 12 of 46